NASDAQ
8.09USD
+1.39 (+20.75%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
72.9M
P/E
—
EPS
—
Beta
0.89
52W range
4.16-10.495
Day range
6.35–8.82
Open
6.51
Prev close
6.70
Volume
214K
Avg volume
112.1K
Dividend
0.00
IPO
2018-06-22
https://www.proactiveinvestors.com/companies/news/1096191/ecora-royalties-reports-61-jump-in-strong-quarter-1096191.html · 7/29/2026+1.00
https://www.accessnewswire.com/newsroom/en/metals-and-mining/ecora-royalties-plc-announces-q2-2026-trading-update-1197872 · 7/29/2026+0.80
https://www.accessnewswire.com/newsroom/en/metals-and-mining/ecora-resources-plc-announces-update-on-the-phalaborwa-rare-earths-project-dfs-1185020 · 7/1/2026+0.60
https://www.barrons.com/articles/petrobras-ecopetrol-energy-stocks-upside-technical-analysis-1db8ced7 · 6/8/2026+0.80
https://www.proactiveinvestors.com/companies/news/1091606/ecora-royalties-has-confirmed-a-strong-start-to-2026-icymi-1091606.html · 5/2/2026+0.90
https://www.proactiveinvestors.co.uk/companies/news/1091606 · 5/2/2026+0.90
https://www.reuters.com/business/energy/colombias-ecopetrol-buy-26-stake-brazils-brava-seeks-majority-control-2026-04-23/ · 4/23/2026+0.30
https://www.proactiveinvestors.co.uk/companies/news/1090084 · 4/7/2026+0.70
https://www.zacks.com/stock/news/2886947/electrocore-inc-ecor-reports-q4-loss-lags-revenue-estimates?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_4-2886947 · 3/19/2026-0.20
https://www.proactiveinvestors.co.uk/companies/news/1089074 · 3/18/2026+0.80
https://www.accessnewswire.com/newsroom/en/metals-and-mining/ecora-royalties-plc-announces-transfer-of-treasury-shares-and-total-voting-rights-1140495 · 2/24/2026+0.00
https://www.proactiveinvestors.co.uk/companies/news/1080384 · 10/15/2025+0.90
electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
